Back to search results

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Mesothelin Positive · Mesothelin-Expressing Tumors · Esophageal Adenocarcinoma · Esophageal Adenocarcinomas · Esophagogastric Adenocarcinoma · Peritoneal Carcinomatosis · Breast Neoplasms · Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Geoffrey Ku, MD) · 646-888-4588

  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Geoffrey Ku, MD) · 646-888-4588

  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Geoffrey Ku, MD) · 646-888-4588

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Geoffrey Ku, MD) · 646-888-4588

  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Geoffrey Ku, MD) · 646-888-4588

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Geoffrey Ku, MD) · 646-888-4588
    Contact: Principal Investigator (Geoffrey Ku, MD)

  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Geoffrey Ku, MD) · 646-888-4588
Study leads

  • Geoffrey Ku, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)